改变的风:一个关于:喘和微生物组的故事
David Galeana-Cadena1, Itzel Alejandra Gómez-García1,2, Karen Gabriel Lopez-Salinas1,2
1Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas (INER), Mexico City, Mexico.
Frontiers in microbiology
|December 26, 2023
概括
肠道微生物组可能会防止喘,而像海莫菲勒斯这样的呼吸道微生物可以使它恶化. 了解这种微生物联系是新的喘治疗的关键.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
背景情况:
- 人类微生物组在免疫系统的发育和功能中起着至关重要的作用.
- 微生物群落的变化 (失生症) 越来越多地与包括喘在内的各种疾病有关.
- 喘是一种慢性呼吸道疾病,其特点是气道炎症和高反应性.
研究的目的:
- 审查微生物群对喘病原和表型的影响.
- 探索肠道和呼吸道微生物群与喘发育之间的关系.
- 为了确定新的喘疗法潜在的微生物点.
主要方法:
- 对队列研究和关于微生物组和喘的研究的文献综述.
- 分析特定微生物属与喘保护或发病之间的关联.
- 检查呼吸道感染对气道微生物群的影响.
主要成果:
- 肠道微生物群中的保护性属包括Bifidobacterium,Lactobacillus,Faecalibacterium和Bacteroides. 这些是肠道微生物群中的保护性属.
- 在呼吸道微生物群中涉及喘的致病性属包括Haemophilus,Streptococcus,Staphylococcus和Moraxella.
- 呼吸道感染可以改变上呼吸道微生物群,增加对细菌疾病和喘恶化的易感性.
结论:
- 肠道和呼吸系统的微生物组显著影响喘的发展和进展.
- 微生物失生症是喘发病的一个关键因素.
- 准微生物组为开发创新的喘治疗提供了一个有希望的途径.
相关概念视频
01:29Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:20Asthma: Pathogenesis and Management
411
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
411
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
305
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
305